Glucose Transport in Human Red Blood Cells
American Journal of Biomedical and Life Sciences
Volume 1, Issue 3, October 2013, Pages: 44-52
Received: Sep. 27, 2013; Published: Oct. 30, 2013
Views 3354      Downloads 646
Author
Omar S. Hajjawi, Department of Biology, Arab American University, P.O. Box 240, Jenin, Israeli Occupied Territories of Palestine
Article Tools
PDF
Follow on us
Abstract
The penetration of D-[14C] glucose into human red blood cells (RBCs) features kinetic parameters which are readily distinguishable from passive permeation. It would be expected to require activation energy above 80 kJ/mol for permeation of glucose with five hydroxyls capable of forming hydrogen bonds, but the measured activation energy is approximately 16 kJ/mol. As a consequence, glucose permeates RBC membrane about five orders of magnitude faster than would be expected for passive permeation. Glucose transporter protein 1, or GLUT1 and SGLT1, present in all human tissues, but especially in RBCs. It is also anchored in the protective sheet of flat cells that line up the blood vessels of the brain. GLUT1 has a strong affinity for glucose and it ensures that both RBCs and the brain receive appropriate levels of glucose that they need to be able to function. The brain consumes ~120g of glucose per day; the blood glucose level in a typical person 80mg/100ml. The binding site of glucose faces intracellular and extracellular of the membrane alternately when it is loaded by a glucose. The transport is accomplished by conformational changes within GLUT1 , and not by rotation of the whole single long polypeptide chain (55kD, ~500 residues) with the presence of 12 trans membrane α-helices segments. The super family of related GLUT sugar transporters comprises 14 identified isoforms in the human genome, all adopting a 12-membrane–spanning domain structure that delineate 6 extracellular loops .The erythrocyte glucose transporter GLUT1 has an ~10-fold-lower affinity for D-glucose, Km ≈ 10–15 mM, at the inside face for net export than on the outside (Km = 1–2 mM) for net import of glucose (zero-trans net flux) at 24°C , pertaining a liganded consequential asymmetric transporter.
Keywords
D-[14C]Glucose Transporter (GLUT1), Secondary Active Glucose Transporter (SGLT), Membrane Transport, Glucose Transporter Gene (GLUT1 cDNA), Erythrocytes, Glycogenolysis, Diabetes Mellitus, D-Glucose, Facilitated Transport, Cytochalasin B (CB), Na+/K+-ATPase Pump, Carbamazepine, Simvastatin.
To cite this article
Omar S. Hajjawi, Glucose Transport in Human Red Blood Cells, American Journal of Biomedical and Life Sciences. Vol. 1, No. 3, 2013, pp. 44-52. doi: 10.11648/j.ajbls.20130103.12
References
[1]
H. Dryerre, W.G. Millar, and E. Ponder (1926) "An investigation into the size of human erythrocytes before and after exercise", Experimantal Physiology, vol. 16, pp.69-86.
[2]
P.B. Canham and A.C. Burton (1968) " Distribution of size and shape in population of normal human red cells", Circ. Res., vol. 22, pp. 405-422.
[3]
R.I. Sha’afi (1977) Water and Small Nonelectrolyte Permeation in Red Cells, in Ellory, J.C. and Lew, V.L.(eds.) ,Membrane Transport in Red Cells, pp.221- 256. London: Academy Press Inc. (London) Ltd.
[4]
W.F. Ganong (2003) Medical Physiology, 21st edn. Los Altos,CA: Lange Medical.
[5]
G. W. Gould (1997) Facilitative Glucose Transporters. Austin, TX: R.G. Landas Co.
[6]
J.C.Ellory and V.L. Lew (1977) Membrane Transport in Red cells. London: Academic Press.
[7]
L.Michaelis and M.L.Menten (1913) "Die kinetik der invertinwirkung ", Biochem. Zeitschr, vol.49, pp.333-369.
[8]
L.Michaelis, M.L.Menten, K.L. Johnson, and R.S. Goody, (2011) "The original Michaelis constant: translation of the 1913 Michaelis-Menten paper", Biochemistry, vol.50 (39), pp.8264-8269.
[9]
D.L. Nelson and M.M.Cox (2008) Lehninger Principles of Biochemistry, 5th edn. New York, NY: W.H.Freeman and Company.
[10]
E. Beutler (1996) "G6PD population on genetics and clinical manifestations", Blood Rev., vol.10, pp.45-52.
[11]
L. Luzzatto (2006) "Glucose 6-phosphate dehydrogenase deficiency: from genotype to phenotype ", Haematologica, vol.91, pp.1303–1306.
[12]
L. Bordin, F. Zen, F. Ion-Popa, M. Barbetta, B. Baggio and G. Clari (2005) "Band 3 tyr-phosphorylation in normal and glucose-6-phospate dehydrogenase- deficient human erythrocytes", Mol. Membr. Biol., vol.22 (5), pp.411-420.
[13]
J.E. Frank (2005) "Diagnosis and management of G6PD deficiency", Am. Fam. Physician, vol. 72, pp.1277–1282.
[14]
A.L. Peters and C.I.F.Van Noorden (2009) "Glucose-6-phosphate dehydrogenase deficiency and malaria: cytochemical detection of heterozygous G6PD deficiency in women", J. Histochem Cytochem, vol. 57 (11), pp.1003-1011 .
[15]
G. Jacobasch and S.M. Rapoport (1996) "Hemolytic anemias due to erythrocyte enzyme deficiencies", Mol. Aspects. Med., vol.17 (2), pp.143-170.
[16]
S. H. Webster (1949) "Heinz body phenomenon in erythrocytes a review", Blood, vol.4 (5), pp.479-497.
[17]
W.T. Potter, S. Rong, J. Griffith, J. White and V.F. Garry(1991) "Phosphine- mediated Heinz body formation and hemoglobin oxidation in human erythrocytes", Toxicol Lett. , vol.57(1), pp.37-45.
[18]
S.J. Singer and G.L. Nicholson (1972) "The fluid mosaic model of the structure of cell membrane", Science, vol.175, pp.720-731.
[19]
E. Kajii (1998) "Advance in the Rh blood group system", Nihon Hoigakn Zasshi, vol.52 (1), pp.1-18.
[20]
P.G. Gallagher and S.E. Lux (2003) Disorders of the Erythrocyte Membrane, in Hematology of Infancy and Childhood, Nathan,D.G., Orkin, S.H., Ginsberg, D. and Look, T.A. (eds), p.560-684. Philadelphia, PA : WB Saunders.
[21]
J.F. Flatt and L.J.Bruce (2009) "The hereditary stomatocytoses", Haematologica, vol. 94 (8), pp.1039-1041.
[22]
M.E. Reid and C. Lomas-Francis (2004) The Blood Group Antigen Facts Book, 2nd edn. New York, NY: Elsevier Academic Press.
[23]
I. Bernhardt and J.C. Ellory (2003) Red Cell Membrane Transport in Health and Disease. Berlin: Springer-Verlag.
[24]
P.H.B. Bolton-Maggs, R.F. Stevens, N.J. Dodd,G. Lamont, P. Tittensor and M.J.King (2004) "Guidelines for the diagnosis and management of hereditary spherocytosis", British Journal of Haematology,vol.126, pp.455–474. doi:10.1111/j.1365-2141.2004.05052.x
[25]
R.M. Bannerman and J.H. Renwick (1962) " The hereditary elliptooytoses: clinical and linkage data", Annals Human Genetics Lond., vol.26 (1), pp.23–38.
[26]
J. Knight and D.R. Czuchlewski (2013) "Acquired elliptocytosis of myelodysplastic Syndrome", Blood , vol. 121 (4), p. 572.
[27]
C.J. Parker (2002) "Historical aspects of paroxysmal nocturnal haemoglobinuria: `defining the disease' ", Br.J. Haematol. , vol.117, pp. 3-22.
[28]
D.J. Araten, H.T. Thaler and L. Luzzatto (2005) "High incidence of thrombosis in African-American and Latin-American patients with paroxysmal nocturnal Haemoglobinuria", Thromb Haemost, vol.93, pp. 88-91.
[29]
W.W. Umbreit, R.H. Burris and J.F. Stauffer (1946) Manometric Techniques, p.194. Minneapolis, MN: Burgess Publishing Co.
[30]
C.G. Winter and H.N. Christensen (1964) "Contrasts in neutral amino acid transport and rabbit erythrocyte and reticulocytes", J. Biol. Chem, vol.239, pp.872-878.
[31]
E. Eavenson and H.N. Christensen (1967) "Transport systems for neutral amino acids in the pigeon erythrocyte", J.Biol. Chem., vol.242, pp. 5386-5396.
[32]
R. Rosenberg and O.J. Rafaelsen (1979) "Transport of neutral amino acids across the human red blood cell membrane", J.G.Physiol, vol 41, pp.289-296.
[33]
D.M. Miller (1968) "The kinetics of selective biological transport. III. Erythrocyte- monosaccharide transport data", Biophys J , vol.8, pp. 1329–1338.
[34]
S.L. Ørskov (1935) "A method for continuous photographic recording of volume changes in red blood cells. Studies on the influence of temperature and of hydrogen- ion concentration on the rate of permeability of glycerol and urea" Biochem, Z., vol.279, pp.241-249.
[35]
J.F. Leitch and A. Carruthers (2009) "α-and β-Monosacharide transport in human erythrocytes", Am. J. Physiol. Cell physiol., vol.296 (1), pp.C151- C161.
[36]
M.A. Zoccoli,S.A. Baldwin and G.E. Lienhard (1978) "The monosaccharide transport system of the human erythrocyte. Solubilization and characterization on the basis of cytochalasin B binding", J.Biol. Chem., vol.253, pp.6923-6930.
[37]
E.K. Cloherty, K.S. Heard and A. Carruthers (2001) "The red blood cell glucose transporter presents multiple ,nucleotide-sensitive sugar exit sites", Biochemistry, vol.40 (51), pp. 15549-15561.
[38]
L.E. Lenox, J.M. Perry and R.F. Paulson (2005) "BMP4 and MaCDS and MADH regulate the erythroid response to acute anemia", Blood, vol.105, pp.2741-2748.
[39]
G.F. Baker and R.J. Naftalin (1979) "Evidence of multiple operational affinities for D- glucose inside the human erythrocyte membrane" , Biochim. Biophys. Acta, vol.550, pp.474-484.
[40]
A. Carruthers, J. De Zutter, A. Ganguly and S. Devaskar (2009) "Will the original glucose transporter isoform please stand up", Am. J. Physiol. Endocrinol. Metab, vol.297 (4), pp. E836-E848.
[41]
W.D. Stein (1989) "Kinetics of transport: analyzing, testing, and characterizing models using kinetic approaches", Methods Enzymol.,vol.171, pp.23–62.
[42]
E.M. Wright, D.D.F. Loo and B.A. Hirayama (2011) "Biology of human sodium glucose transporters", Physiol Rev , vol. 91(2), pp.733-794
[43]
J.Z. Zhang, W. Abbud, R. Prohaska and F. Ismail-Beigi (2001) "Overexpression of stomatin depression GLUT-1 glucose transporter activity", Am.J.Physiol. Cell Physiol., vol.280, pp.C1277-1283.
[44]
U. Salzer, M. Mairhofer and R. Prohaska (2007) " Stomatin: a new paradigm of membrane organization emerges", DYN Cell Biol., vol.1, pp.20-33.
[45]
A.G. Lowe and A.R. Walmsley (1986) "The kinetics of glucose transport in human red blood cells", Biochim Biophys Acta, vol. 857, pp. 146–154.
[46]
R.J. Naftalin (2008) "Alternating carrier model of asymmetric glucose transporter violate the energy conservation laws", Biophysical J., vol.95, pp.4300-4314.
[47]
D.M. Blodgett and A. Carruthers (2005) "Quench-flow analysis reveals multiple phases of GluT1-mediated sugar transporter", Biochemistry, vol.44 (7), pp.2650-2660.
[48]
P.K. Gasbjerg and J. Brahm (1991) "Glucose transport kinetics in human red blood cells",Biochim. Biophys. Acta, vol.1062(1), pp. 83-93.
[49]
Vollers, S. S. (2013) "Identification and analysis of the domain required for trans- acceleration kinetics in the human glucose transporter GLUT1: a dissertation", University of Massachusetts Medical School. Retrieved May 29, 2013 from http://escholarship.umassmed.edu/gsbs_diss/645
[50]
P. Zancan and M. Sola-Penna (2005) "Calcium influx: a possible role for insulin modulation of intracellular distribution and activity of 6-phosphofructo- 1-kinase in human erythrocytes", Mol. Cenet. Metab., vol.86, pp.392-400.
[51]
A. Casey, R. Mann, K. Banister, J. Fox, P.G. Morris, A. Ian, I.A. Macdonald and P.L. Greenhaff (2000) "Effect of carbohydrate ingestion on glycogen resynthesis in human liver and skeletal muscle, measured by 13C MRS", Am.J. Physiology- Endo , vol. 278 no. 1 , pp.E65-E75
[52]
L. Stryer (1995) Biochemistry, 4th edn. New York, NY: H.W. Freeman and Company.
[53]
M. Elia (2000) "Hunger disease", Clin. Nutr., vol.19 (6), pp.379-386.
[54]
G.F. Cahill and R.L. Veech (2003) "Ketoacids? Good medicine?", Trans. Am. Clin. Clim. Ass., vol. 114, pp.149-163.
[55]
D. Sadava and G. Orians (2000) Life: The Science of Biology. New York, NY: W. H. Freeman and Co.
[56]
British Athletic Federation (1992) Senior Coach - Coaching Theory Manual. 3rd edn. Windsor, Berkshire: Reedprint Ltd.
[57]
Dietary Guidelines for Americans (2010) " Evolution of the Dietary Guidelines for Americans 2005 to 2010". Retrieved June 23, 2013 from http://www.nationaldairycouncil.org/SiteCollectionDocuments/education_ materials/dietary_guidance.
[58]
R.M. Begum (2008) Textbook of Foods, Nutrition & Dietetics, 3rd edn. Okhla Industrial Area, New Delhi,India: Sterling Publishers Pvt. Ltd.
[59]
A.L. Helgerson and A. Carruthers (1987) "Equilibrium ligand binding to the human ertythrocyte sugar tranporter: evidence for two sugar-binding sites per carrier", J.Biol. Chem., vol.262, pp. 5464-5475.
[60]
A.L. Olson (2012) "Regulation of GLUT4 and insulin-dependent glucose flux", Mol. Biol., vol.2012, Article ID 856987. Retrieved June 23, 2013 from http://www.hindawi.com/isrn/mb/2012/856987. doi: 10.5402/2012/856987
[61]
P.J. O’Connor, N. Bodkin,J. Fradkin, R. Glasgow,S. Greenfield, E. Gregg, E.A. Kerr, L.G. Pawlson, J.V. Selby, J.E. Sutherland, M.C. Taylor and C.H. Wysham (2011) " Diabetes performance measures: current status and future directions", Diabetes Care, vol. 34, pp.1651-1659 ; pp.1651-1659.
[62]
J. Seifter, A.Ratner and D. Sloane (2005) Concepts in Medical Physiology. Baltimore, MD: Lippincott Williams & Wilkins.
[63]
H. Yang, D. Wang, K. Engelstad, L. Bagay, Y. Wei, M. Rotstein, V. Aggarwal, B. Levy, L. Ma, W.K. Chung and D.C. De Vivo (2011) "Glut1 deficiency syndrome and erythrocyte glucose uptake assay", Ann. Neurol., vol.70, pp.996–1005.
[64]
P.R. Shepherd and B.B.Kahn (1999) "Glucose transporters and insulin action implications for insulin resistance and diabetes mellitus", N. Engl. J. Med., vol. 341 (4), pp. 248-257.
[65]
T.E. Graham and B.B. Khan (2007) "Tissue-specific alterations of glucose transport and molecular mechanisms of intertissue communication in obesity and type 2 diabetes", Horm. Metab. Res.,vol. 39(10), pp.717-721.
[66]
G. Wilcox (2005) "Insulin and insulin resistance", Clin. Biochem. Rev., vol. 26 (2), pp.19-39.
[67]
E.M. Bingham, D. Hopkins, D. Smith, W. Pernet, W Hallett, L. Reed, P.K. Marsden and S.A. Amiel (2002) "The role of insulin in human brain glucose metabolism: an 18Fluoro-deoxyglucose positron emission tomography study", Diabetes, vol. 51 (12), pp. 3384-3390.
[68]
D. Brealey and M. Singer (2009) " Hyperglycemia in critical illness: a review", J. Diabetes Sci. Technol., vol. 3(6), pp. 1250-1260.
[69]
R.A. De Fronzo, E. Ferrannini, H. Keen and P. Zimmet (2004) International Textbook of Diabetes Mellitus, vol. 1. 3rd edn. Hoboken, NJ: John Wiley & Sons.
[70]
R.M. O’Brien and D.K. Granner (1996) "Regulation of gene expression by insulin", Physiol Rev., vol. 76, pp.1109-1161.
[71]
P. Cohen (2006) "The twentieth century struggle to decipher insulin signaling", Nat. Rev. Mol. Cell Biol., vol. 7, pp. 867-873.
[72]
M. Bluher, J. Kratzsch and R. Paschke (2001) " Plasma levels of tumor necrosis factor-alpha, angiotensin II, growth hormone, and IGF-I are not elevated in insulin-resistant obese individuals with impaired glucose tolerance", Diabetes Care, vol.24, pp. 328–334.
[73]
B.M. Spiegelman and J.S.Flier (2001) " Obesity and the regulation of energy balance", Cell, vol. 104 , pp.531–543.
[74]
M. Fasshauer, S. Kralisch, M. Klier, K. Lossner, M.M. Bluher, J. Klein and R. Raschke (2004) "Insulin resistance-inducing cytokines differentially regulate SOCS mRNA expression via growth factor- and Jak/Stat-signaling pathways in 3T3-L1 adipocytes", J. Endocrinology, vol.181, pp. 129-138.
[75]
T. Wada, S. Hori, M. Sugiyamu, E. Fujisawa, T. Nakano, H. Tsuneki, K. Nagira, S. Saito and T. Sasaoka (2010 "Progesterone inhibits glucose uptake by affecting diverse steps of insulin signaling in 3T3-L1 adipocytes", Am. J. Physiol-Endo, vol.298 (4), pp. E881-888.
[76]
Bannerman, R. M. and Renwick, J. H. (1962) " The hereditary elliptooytoses: clinical and linkage data", Annals Human Genetics Lond., vol.26 (1), pp.23–38.
ADDRESS
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
U.S.A.
Tel: (001)347-983-5186